Skip to main content
. 2017 Jun 19;114(27):E5352–E5361. doi: 10.1073/pnas.1703071114

Table S1.

Drugs screened for the effect on BRD4 hyperphosphorylation

Name Target Effect on BRD4 hyperphosphorylation
Ibrutinib BTK No effect
Idelalisib PI3K (p110δ) No effect
Trametinib MEK1/2 No effect
TBB CKII No effect
LDC000067 CDK9 Inhibits BRD4 hyperphosphorylation in HCC2429
PHA767491 CDK9/CDC7 Inhibits BRD4 hyperphosphorylation in HCC2429
Flavopiridol CDKs Inhibits BRD4 hyperphosphorylation in HCC2429
DRB CDK9 and many other kinases Inhibits BRD4 hyperphosphorylation in HCC2429
Apigenin CDK9 and many other kinases Inhibits BRD4 hyperphosphorylation in HCC2429
Wortmannin PI3K/ATM No effect
Danusertib Aurora A/B/C No effect
Sotrastaurin pan-PKC No effect
MK-2206 Akt1/2/3 No effect
KU-55933 ATM No effect
D4476 CKI No effect
CHIR99021 GSK-3α/β No effect
SRPIN340 SRPK1 No effect
NU7441 DNA-PK No effect
Palbociclib CDK4/6 No effect
3-Deazaneplanocin A (DZNep) EZH2 No effect
BIX01294 G9a No effect
GSK343 EZH2 No effect
CPI-169 EZH2 No effect
C646 p300 Inhibits BRD4 hyperphosphorylation in HCC2429
(+)-JQ1 BRD4 and other BET proteins Reduces BRD4 hyperphosphorylation in HCC2429
HMBA Releases P-TEFb, induces HEXIM1, also targets p300 and BRD4 Reduces BRD4 hyperphosphorylation in HCC2429